Sales & Earnings In Brief
This article was originally published in The Tan Sheet
GNC passes $2B in annual revenue; launches lift Watson earnings; NAI benefits from FDA supplement crackdown; PuraMed turns corner with LipiGesic M product rollout.
You may also be interested in...
The goal is to create a program which mass sequences SARS-CoV-2 samples in order to detect new variants, with £30m injected into the UK's hub for genomic sequencing in Cambridge.
More than half a dozen generic rivaroxaban brands are now available in India, putting the heat on Bayer’s blockbuster anticoagulant Xarelto in the price-sensitive market. Many rival generics are priced over 50% lower than the innovator product.
The French government has decided not to extend the recommended interval between the two doses of the Pfizer/BioNTech coronavirus vaccine.